Novo Nordisk invests USD 2.6bn in new manufacturing facilities

With an investment of DKK 17bn (USD 2.6bn), Novo Nordisk seeks to strengthen all of the links in its global value chain, from drug production to packaging, it announces in a press release on Monday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app